FDAClass IIAugust 9, 2023

EPINEPHrine 8mg/250ml added to dextrose 5% recall: Sterility Concern

EPINEPHrine 8mg/250ml added to dextrose 5%, 32 mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ…

Why was EPINEPHrine 8mg/250ml added to dextrose 5% recalled?

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 36-240224, Exp. 7/16/2023; 36-242322, EXP. 7/24/2023; 36-242445, Exp. 7/25/2023; 36-243305, Exp. 7/27/2023; 36-243813, Exp. 7/31/2023; 36-246166, 36-246167, Exp. 8/3/2023; 36-247670, Exp. 8/9/2023; 36-248992, Exp.8/16/2023; 36-249468, Exp. 8/17/2023; 36-249590, Exp.8/18/2023; 36-251336, 36-251644, Exp. 8/27/2023; 36-251461, Exp. 8/28/2023; 36-255531, 36-255532, Exp. 9/7/2023.

Product
EPINEPHrine 8mg/250ml added to dextrose 5%, 32 mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ…
Recalling firm
Central Admixture Pharmacy Services, Inc.
Quantity
4,570 bags
Distribution
Nationwide in the USA
Recall date
August 9, 2023
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls